Show newer

How does the new EU pharma strategy intend to ensure equal access to new medicines, no matter where patients live?
📺 Watch or
📑 Read europa.eu/!BVvGdH
@EP_ScienceTech @MEP_Ehler @IvoHristovMEP @ijabs @FiocchiPietro @weisspernille

🐦🔗: n.respublicae.eu/EP_ThinkTank/

📅 Drop in for a conversation with our policy expert on How can the EU counter radicalisation?
Tomorrow at the @europarl_en InfoHub at 12:00 (no registration required)
eptwitter.eu/qB9S
@EP_Justice

🐦🔗: n.respublicae.eu/EP_ThinkTank/

Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing
📽️👇 Watch 5 facts about access to new medicines
📘 Read eptwitter.eu/qBD2
@EP_PublicHealth

🐦🔗: n.respublicae.eu/EP_ThinkTank/

Rare disease patients often spend years enduring a “diagnostic odyssey”
What if quantum technologies were to revolutionise healthcare?
📺 Watch or
📑 Read
europarl.europa.eu/thinktank/e
@sara_saracerdas @VTrillet_Lenoir @luisaregimenti @MicheleRivasi @j_kopcinska @Konecna_K

🐦🔗: n.respublicae.eu/EP_ThinkTank/

The 2022 energy crisis brought new challenges for the EU market
⚡️high prices
⚡️supply security
⚡️push to increase decarbonisation
sparking need for a redesign
wp.me/p2qdgs-fcd
@EP_Industry @CristianSBusoi @ZdzKrasnodebski @mortenhelveg @toiapatrizia

🐦🔗: n.respublicae.eu/EP_ThinkTank/

🏭 Air pollution is a serious issue with tangible negative effects on health, the environment, economies and societies.
Can the EU improve air quality?
eptwitter.eu/qBa8
@EP_Environment @pcanfin @rmkanev @MChahim @MichalWiezik @eleonoraevi @AnnaZalewskaMEP @mmatias_

🐦🔗: n.respublicae.eu/EP_ThinkTank/

As @EU_Commission prepares to launch a revised EU strategy, we look at options to tackle weaknesses in drug development & access to high-quality medicines
🎧 Listen 👇
📘 Read
epthinktank.eu/2023/01/04/towa
@EP_Environment @EP_PublicHealth

🐦🔗: n.respublicae.eu/EP_ThinkTank/

New EU rules on excessive and concentrated exposures to third-country central counterparties aim for additional control over clearing in third-country CCPs posing systemic risks, while making EU CCPs more attractive
wp.me/p2qdgs-ffG
@EP_Economics @itinagli @danutahuebner

🐦🔗: n.respublicae.eu/EP_ThinkTank/

Antimicrobial resistance is estimated to surpass cancer as the second largest cause of death by 2050
📅 Join us at @EP_ScienceTech event on 29 Mar, 10:00-12:00 to discuss how to tackle this growing public health crisis
✍️ eptwitter.eu/qBAb
@ellenthoen @AnthroAMR

🐦🔗: n.respublicae.eu/EP_ThinkTank/

Show older
Mastodon

A Mastodon forum for the discussion of European Union matters. Not run by the EU. Powered by PleromaBot, Nitter and PrivacyDev.net.